Skip to content

Medical emergency? What to do

US FDA warns Bayer on hemophilia therapy promotion

3-RXPublished January 25, 20061 min read

Key points

  • A number of Bayer AG promotions for its hemophilia treatment Kogenate FS ae misleading because they fail to include ample information about risks and directions for use, U.S. regulators said in a letter released on Tuesday.
  • "By failing to include sufficient information on risks and adequate directions for use, you have encouraged the potentially unsafe use of Kogenate FS," the FDA said in a letter to the company.
  • The most common potential side effects from Kogenate FS include reactions at the injection site, dizziness and rash.
  • The Food and Drug Administration objected to letters to patients and doctors about a free trial program for Kogenate FS.

A number of Bayer AG promotions for its hemophilia treatment Kogenate FS ae misleading because they fail to include ample information about risks and directions for use, U.S. regulators said in a letter released on Tuesday.

The Food and Drug Administration objected to letters to patients and doctors about a free trial program for Kogenate FS.

"By failing to include sufficient information on risks and adequate directions for use, you have encouraged the potentially unsafe use of Kogenate FS," the FDA said in a letter to the company.

The agency told Bayer to stop using the letters or any similar promotions that are misleading.

The most common potential side effects from Kogenate FS include reactions at the injection site, dizziness and rash.

A Bayer spokeswoman could not immediately be reached for comment.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug News

Keep reading

Cancer

Avastin Slows Resistant Ovarian Cancer

Progression of platinum-resistant ovarian cancer slowed by more than 50% in patients who received bevacizumab (Avastin) plus chemotherapy compared with nonplatinum chemotherapy alone, results of a randomized trial…

3 min read

Drug News

Prevnar trial results needed for CDC recommendation

Advisors to the U.S. Centers for Disease Control and Prevention on Wednesday will wait for results from a trial of Pfizer Inc's Prevnar 13 pneumonia vaccine before deciding whether to recommend its use in all adults…

1 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.